Direct-acting antiviral agents in the therapy of hepatitis C virus-related mixed cryoglobulinaemia: a single-centre experience

Direct-acting antiviral agents in the therapy of hepatitis C virus-related mixed cryoglobulinaemia: a single-centre experience

Abstract Background The efficacy and safety of direct-acting antiviral agents (DAAs) were evaluated in a cohort of prospectively enrolled patients with hepatitis C virus (HCV)-related mixed cryoglobulinaemia (MC), an immune complex-mediated vasculitis of small and medium vessels in which the pathoge...

Full description

Bibliographic Details
Main Authors: Gianfranco Lauletta, Sabino Russi, Fabio Pavone, Angelo Vacca, Franco Dammacco
Format: Article
Language:English
Published: BMC 2017-04-01
Series:Arthritis Research & Therapy
Subjects:
Cryoglobulinaemia
Direct-acting antiviral agents
Hepatitis C virus
Rheumatoid factor
Online Access:http://link.springer.com/article/10.1186/s13075-017-1280-6

Internet

http://link.springer.com/article/10.1186/s13075-017-1280-6

Similar Items